Trial Profile
Takepron Capsules 15/ Orally Dispersing(OD) Tablets 15 Special Drug Use Surveillance Long-term Use Survey on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2016
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary)
- Indications NSAID-induced ulcer
- Focus Adverse reactions
- Sponsors Takeda
- 10 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Apr 2014 New trial record